27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy: Analysis of Esophagectomies in the Japanese National Clinical Database

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Esophagectomy followed by gastric conduit reconstruction is a standard surgical procedure for esophageal cancer. However, there is no evidence of the superiority or inferiority of the posterior mediastinal (PM) versus the retrosternal (RS) reconstruction route with regard to short‐term outcomes after esophagectomy. We aimed to elucidate whether the reconstruction route can affect the short‐term outcomes after esophagectomy followed by gastric conduit reconstruction.

          Methods

          We reviewed the clinical data of patients who underwent esophagectomy between 2016 and 2018 from the Japanese National Clinical Database. This study included 9786 patients who underwent gastric conduit reconstruction through the PM or RS route with cervical anastomosis.

          Results

          Of the 9786 patients analyzed, 3478 and 6308 underwent gastric conduit reconstruction thorough the PM and RS routes, respectively. The incidence of anastomotic leak and surgical site infection (SSI) was significantly lower in the PM group than in the RS group (11.7% vs 13.8%, P = .005 and 8.4% vs 14.9%, P < .001, respectively), while the incidence of pneumonia was higher in the PM group (13.7% vs 12.2%, P = .040). Generalized estimating equation logistic regression analysis revealed a higher risk of anastomotic leak and SSI (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.15–1.51; P < .001 and OR, 2.06; 95% CI, 1.78–2.38; P < .001, respectively) and a lower risk of pneumonia (OR, 0.86; 95% CI, 0.75–0.98; P = .028) in the RS group than in the PM group.

          Conclusion

          The findings of this study will help surgeons to design the reconstruction route following esophagectomy.

          Abstract

          We reviewed the clinical data of patients who underwent esophagectomy from the Japanese National Clinical Database to elucidate whether the reconstruction route can affect the short‐term outcomes. The retrosternal route was identified as a risk factor for anastomotic leak and surgical site infection, and the posterior mediastinal (PM) route for pneumonia.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Preoperative chemoradiotherapy for esophageal or junctional cancer.

            The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population. We randomly assigned patients with resectable tumors to receive surgery alone or weekly administration of carboplatin (doses titrated to achieve an area under the curve of 2 mg per milliliter per minute) and paclitaxel (50 mg per square meter of body-surface area) for 5 weeks and concurrent radiotherapy (41.4 Gy in 23 fractions, 5 days per week), followed by surgery. From March 2004 through December 2008, we enrolled 368 patients, 366 of whom were included in the analysis: 275 (75%) had adenocarcinoma, 84 (23%) had squamous-cell carcinoma, and 7 (2%) had large-cell undifferentiated carcinoma. Of the 366 patients, 178 were randomly assigned to chemoradiotherapy followed by surgery, and 188 to surgery alone. The most common major hematologic toxic effects in the chemoradiotherapy-surgery group were leukopenia (6%) and neutropenia (2%); the most common major nonhematologic toxic effects were anorexia (5%) and fatigue (3%). Complete resection with no tumor within 1 mm of the resection margins (R0) was achieved in 92% of patients in the chemoradiotherapy-surgery group versus 69% in the surgery group (P<0.001). A pathological complete response was achieved in 47 of 161 patients (29%) who underwent resection after chemoradiotherapy. Postoperative complications were similar in the two treatment groups, and in-hospital mortality was 4% in both. Median overall survival was 49.4 months in the chemoradiotherapy-surgery group versus 24.0 months in the surgery group. Overall survival was significantly better in the chemoradiotherapy-surgery group (hazard ratio, 0.657; 95% confidence interval, 0.495 to 0.871; P=0.003). Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation [KWF Kankerbestrijding]; Netherlands Trial Register number, NTR487.).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oesophageal carcinoma.

              Oesophageal carcinoma affects more than 450,000 people worldwide and the incidence is rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal carcinoma worldwide, but a shift in epidemiology has been seen in Australia, the UK, the USA, and some western European countries (eg, Finland, France, and the Netherlands), where the incidence of adenocarcinoma now exceeds that of squamous-cell types. The overall 5-year survival of patients with oesophageal carcinoma ranges from 15% to 25%. Diagnoses made at earlier stages are associated with better outcomes than those made at later stages. In this Seminar we discuss the epidemiology, pathophysiology, diagnosis and staging, management, prevention, and advances in the treatment of oesophageal carcinoma. Copyright © 2013 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                takeuchi@hama-med.ac.jp
                Journal
                Ann Gastroenterol Surg
                Ann Gastroenterol Surg
                10.1002/(ISSN)2475-0328
                AGS3
                Annals of Gastroenterological Surgery
                John Wiley and Sons Inc. (Hoboken )
                2475-0328
                06 September 2021
                January 2022
                : 6
                : 1 ( doiID: 10.1002/ags3.v6.1 )
                : 46-53
                Affiliations
                [ 1 ] Department of Surgery Hamamatsu University School of Medicine Hamamatsu Japan
                [ 2 ] Department of Healthcare Quality Assessment The University of Tokyo Tokyo Japan
                [ 3 ] Department of Gastroenterological Surgery Tokai University School of Medicine Isehara Japan
                [ 4 ] Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine Kobe University Kobe Japan
                [ 5 ] Database Committee The Japanese Society of Gastroenterological Surgery Tokyo Japan
                [ 6 ] Department of Frontier Surgery Chiba University Graduate School of Medicine Chiba Japan
                [ 7 ] The Japan Esophageal Society Tokyo Japan
                [ 8 ] Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan
                [ 9 ] Department of Surgery Keio University School of Medicine Tokyo Japan
                [ 10 ] The Japanese Society of Gastroenterological Surgery Tokyo Japan
                Author notes
                [*] [* ] Correspondence

                Hiroya Takeuchi, MD, PhD, Department of Surgery, Hamamatsu University School of Medicine, 1‐20‐1 Handayama, Higashi‐ku, Hamamatsu 431‐3192, Japan.

                Email: takeuchi@ 123456hama-med.ac.jp

                Author information
                https://orcid.org/0000-0002-1776-1020
                https://orcid.org/0000-0003-3337-7595
                https://orcid.org/0000-0001-6130-1753
                https://orcid.org/0000-0002-2727-0241
                https://orcid.org/0000-0002-2335-4704
                https://orcid.org/0000-0002-3947-0128
                Article
                AGS312501
                10.1002/ags3.12501
                8786683
                35106414
                42e5e0ac-8d62-4e63-9574-a573d1134e31
                © 2021 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 10 August 2021
                : 01 June 2021
                : 22 August 2021
                Page count
                Figures: 3, Tables: 2, Pages: 0, Words: 6512
                Funding
                Funded by: Department of Healthcare Quality Assessment
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                January 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.0 mode:remove_FC converted:24.01.2022

                anastomotic leak,national clinical database,pneumonia,posterior mediastinal route,retrosternal route,surgical site infection

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content711

                Cited by15

                Most referenced authors801